Patient Guide: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 76 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05255601
Status: 🟢 Enrolling Now
Condition: Lymphoma, Non-Hodgkin, Hodgkin Disease
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 76 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Phoenix, Arizona
  • • Palo Alto, California
  • • And 73 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma - Join Clinical Trial NCTNCT05255601

How to Join This Clinical Trial - NCTNCT05255601

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Lymphoma, Non-Hodgkin, Hodgkin Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lymphoma, Non-Hodgkin, Hodgkin Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lymphoma, Non-Hodgkin, Hodgkin Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05255601 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 76 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Phoenix, Arizona 85016 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Wilmington, Delaware 19803 - United States

Status: WITHDRAWN

Clinical Research Site

Fort Myers, Florida 33908 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Orlando, Florida 32804 - United States

Status: WITHDRAWN

Clinical Research Site

West Palm Beach, Florida 33407 - United States

Status: WITHDRAWN

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55454 - United States

Status: ACTIVE_NOT_RECRUITING

And 66 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Lymphoma, Non-Hodgkin, Hodgkin Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships